1-5 of 5
Joseph C. Fratantoni
Close
Sort by
Journal Articles

A Highly Efficient, Clinically Applicable Transfection Method to Redirect the Specificity of Immune Cells and Enhance Their Anti-Tumor Capacity

Linhong Li, PhD, Lawrence Wolfraim, PhD, Cornell Allen, Angelia Viley, Hiroyuki Fujisaki, Dario Campana, MD., PhD, Joseph C. Fratantoni, MD, Madhusudan V Peshwa, PhD
Journal: Blood
Blood (2008) 112 (11): 3894.
https://doi.org/10.1182/blood.V112.11.3894.3894
Published: 2008
Journal Articles

Vaccination Strategies for Patients with B-CLL.

Fatma V Okur, MD, Eric Yvon, MS, Gianpietro Dotti, MD, George Carrum, MD, Helen E. Heslop, MD, Malcolm K Brenner, MD, PhD, Joseph C. Fratantoni, MD, Madhusudan V Peshwa, PhD, Linhong Li, PhD
Journal: Blood
Blood (2008) 112 (11): 2106.
https://doi.org/10.1182/blood.V112.11.2106.2106
Published: 2008
Journal Articles

An Improved, Non-Viral Approach for Production of hCD40L + B-CLL Cells for Cancer Immunotherapy.

Linhong Li, PhD, Cornell Allen, MS, Stephanie Feller, MS, Larry Wolfraim, PhD, Angelia Viley, MS, Joseph C. Fratantoni, MD, Linda N. Liu, PhD
Journal: Blood
Blood (2006) 108 (11): 2107.
https://doi.org/10.1182/blood.V108.11.2107.2107
Published: 2006
Journal Articles

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Joseph C. Fratantoni, MD, Linhong Li, PhD, Linda N. Liu, PhD, Madhusudan V. Peshwa, PhD, Malcolm Brenner, MD, PhD, Eric Yvon, MS, George Carrum, MD, Ettore Biagi, MD
Journal: Blood
Blood (2005) 106 (11): 450.
https://doi.org/10.1182/blood.V106.11.450.450
Published: 2005
Journal Articles

Nature of the Defect in Congenital Factor V Deficiency: Study in a Patient With an Acquired Circulating Anticoagulant

Joseph C. Fratantoni, M.D., Margaret Hilgartner, M.D., Ralph L. Nachman, M.D.
Journal: Blood
Blood (1972) 39 (6): 751–758.
https://doi.org/10.1182/blood.V39.6.751.751
Published: 1972